RxDoctor Payments Data

Edward Chen, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Atlanta, GANPI 1801985882

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.0%), grants and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 89.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $8,301 and has fallen 98.5% since, to $125 in 2025.

$12,790in general payments, 2019–2025

Across 72 payments — averaging $177.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • AbbVie$484
  • Abbott$340
  • Bolton Medical Inc$177
  • Edwards Lifesciences$121
  • Pfizer$97
  • plus $114 from 4 others
$2,730in research payments, 2019–2025

Across 1 payment — averaging $2730.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Artivion, Inc.$3K

What the payments were for

  • Consulting fees$5634%
  • Speaking & faculty fees$5,50043%
  • Grants$3,17025%
  • Travel & lodging$1,30410%
  • Food & beverage$2,25418%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)21$11,458
AbbVie(2 entities)38$484
Abbott2$340
Bolton Medical Inc2$177
Edwards Lifesciences1$121
Pfizer4$97
Artivion, Inc.1$52
Johnson & Johnson1$28
Baxter Healthcare1$18
UCB, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,790 in reported general payments places this provider in the 70th percentile of 144 thoracic surgery (cardiothoracic vascular surgery) providers in Georgia.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Georgia

Medicare billing

Part B allowed, 2024
$24,249
Medicare patients
31
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →